BEONE MEDICINES LTD-ADR (ONC) Stock Earnings Estimates
NASDAQ:ONC • US07725L1026
370.64 USD
+8.5 (+2.35%)
At close: Feb 23, 2026
370.65 USD
0.01 (0%)
After Hours: 2/23/2026, 8:07:33 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.566B 26.06% | 17.423B 82.13% | 27.214B 56.19% | 38.114B 40.05% | 46.488B 21.97% | 53.685B 15.48% | 59.16B 10.20% | 63.883B 7.98% | 72.133B 12.91% | 78.018B 8.16% | 87.844B 12.59% | 96.584B 9.95% | |
| EBITDA YoY % growth | N/A -38.91% | N/A 26.94% | N/A 56.75% | 3.953B 213.93% | 7.238B 83.10% | 10.731B 48.26% | 22.05B 105.48% | 31.901B 44.68% | 38.642B 21.13% | 44.551B 15.29% | 30.173B -32.27% | N/A | |
| EBIT YoY % growth | -12.026B -27.00% | -8.751B 27.23% | -4.242B 51.53% | 2.704B 163.75% | 5.729B 111.87% | 8.2B 43.13% | 14.71B 79.39% | 17.63B 19.85% | 22.881B 29.78% | 26.33B 15.07% | 30.459B 15.68% | 34.567B 13.49% | |
| Operating Margin | -125.71% | -50.22% | -15.59% | 7.09% | 12.32% | 15.27% | 24.86% | 27.60% | 31.72% | 33.75% | 34.67% | 35.79% | |
| EPS YoY % growth | -141.14 45.69% | -64.31 54.44% | -50.47 21.52% | 23.57 146.71% | 46.97 99.24% | 67.20 43.07% | 1,294.28 1,826.08% | 1,451.41 12.14% | 1,970.31 35.75% | 2,169.12 10.09% | 2,925.77 34.88% | 3,364.97 15.01% |
All data in CNY
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | 8.68 -97.24% |
| Revenue Q2Q % growth | 10.959B 38.58% |
| EBITDA Q2Q % growth | 1.653B |
| EBIT Q2Q % growth | 1.213B 307.25% |
All data in CNY
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 7.94 188.84% | 8.40 | -0.46 | -5.45% |
| Q2 2025 Q2Q % growth | 5.41 104.68% | 0.42 | 4.99 | 1,187.13% |
| Q1 2025 Q2Q % growth | 124.55 151.87% | -4.14 | 128.69 | 3,109.85% |
| Q4 2024 Q2Q % growth | 314.05 1,260.99% | 16.52 | 297.53 | 1,800.57% |
| Q3 2024 Q2Q % growth | -8.94 -159.34% | -7.28 | -1.66 | -22.81% |
| Q2 2024 Q2Q % growth | -115.45 -323.98% | -12.74 | -102.71 | -805.99% |
| Q1 2024 Q2Q % growth | -240.13 -856.85% | -21.85 | -218.28 | -999.20% |
| Q4 2023 Q2Q % growth | -27.05 18.03% | -11.48 | -15.57 | -135.57% |
| Q3 2023 Q2Q % growth | 15.07 138.68% | -26.33 | 41.40 | 157.25% |
| Q2 2023 Q2Q % growth | -27.23 30.85% | -25.21 | -2.02 | -8.03% |
| Q1 2023 Q2Q % growth | -25.10 15.81% | -24.79 | -0.31 | -1.25% |
| Q4 2022 Q2Q % growth | -33.00 25.20% | -13.16 | -19.84 | -150.68% |
| Q3 2022 Q2Q % growth | -38.96 | -39.07 | 0.11 | 0.28% |
| Q2 2022 Q2Q % growth | -39.38 | -30.81 | -8.57 | -27.81% |
| Q1 2022 Q2Q % growth | -29.81 | -26.47 | -3.34 | -12.63% |
| Q4 2021 Q2Q % growth | -44.12 | -35.29 | -8.83 | -25.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 10.108B 40.84% | 10.247B | -139.487M | -1.36% |
| Q2 2025 Q2Q % growth | 9.47B 40.76% | 8.91B | 560.399M | 6.29% |
| Q1 2025 Q2Q % growth | 8.074B 50.65% | 8.176B | -102.423M | -1.25% |
| Q4 2024 Q2Q % growth | 7.908B 73.88% | 7.496B | 412.084M | 5.50% |
| Q3 2024 Q2Q % growth | 7.176B 27.60% | 7.158B | 18.363M | 0.26% |
| Q2 2024 Q2Q % growth | 6.728B 60.77% | 5.255B | 1.473B | 28.03% |
| Q1 2024 Q2Q % growth | 5.359B 74.78% | 4.557B | 802.338M | 17.61% |
| Q4 2023 Q2Q % growth | 4.548B 68.60% | 4.07B | 478.108M | 11.75% |
| Q3 2023 Q2Q % growth | 5.624B 111.55% | 4.108B | 1.516B | 36.90% |
| Q2 2023 Q2Q % growth | 4.185B 84.97% | 3.256B | 928.839M | 28.53% |
| Q1 2023 Q2Q % growth | 3.066B 57.42% | 2.897B | 169.389M | 5.85% |
| Q4 2022 Q2Q % growth | 2.698B 98.00% | 2.44B | 257.639M | 10.56% |
| Q3 2022 Q2Q % growth | 2.659B 99.05% | 2.406B | 252.516M | 10.50% |
| Q2 2022 Q2Q % growth | 2.262B 135.16% | 2.048B | 214.396M | 10.47% |
| Q1 2022 Q2Q % growth | 1.948B -50.42% | 1.838B | 109.858M | 5.98% |
| Q4 2021 Q2Q % growth | 1.362B 105.94% | 1.413B | -50.562M | -3.58% |
| Q3 2021 Q2Q % growth | 1.336B -8.44% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -13.89% | 0% | 63.46% |
| Revenue | 0% | 0% | 0.49% | 1.26% |